In a statement issued on June 4, 2023, in Mexico City, the Federal Commission for Protection against Health Risks(COFEPRIS – Federal Commission for the Protection against Sanitary Risks – Regulatory Agency of Mexico) reported that, according to the most recent Biweekly Therapeutic Expansion Report, authorizations have been granted for a total of 179 health inputs, encompassing the categories of drugs, medical devices, and clinical trials. One relevant clinical trial was conducted to evaluate a drug intended for the treatment of acute lymphoblastic leukemia. Read more here

ELS can help in the investigation and research of all types of medical devices in Europe and LATAM. 

Please contact your ELS local consultant or through the email:

Contact us

We will contact you as soon as possible.